Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Other Non-Current Liabilities: 2012-2017

Historic Other Non-Current Liabilities for Tenax Therapeutics (TENX) over the last 2 years, with Sep 2017 value amounting to $36,078.

  • Tenax Therapeutics' Other Non-Current Liabilities fell 88.37% to $36,078 in Q3 2017 from the same period last year, while for Sep 2017 it was $36,078, marking a year-over-year decrease of 88.37%. This contributed to the annual value of $226,092 for FY2016, which is N/A change from last year.
  • As of Q3 2017, Tenax Therapeutics' Other Non-Current Liabilities stood at $36,078, which was down 50.00% from $72,157 recorded in Q2 2017.
  • Over the past 5 years, Tenax Therapeutics' Other Non-Current Liabilities peaked at $524,340 during Q4 2015, and registered a low of $36,078 during Q3 2017.
  • Moreover, its 3-year median value for Other Non-Current Liabilities was $226,092 (2016), whereas its average is $227,810.
  • Data for Tenax Therapeutics' Other Non-Current Liabilities shows a maximum YoY slumped of 88.37% (in 2017) over the last 5 years.
  • Quarterly analysis of 4 years shows Tenax Therapeutics' Other Non-Current Liabilities stood at $54,660 in 2013, then reached $524,340 in 2015, then plummeted by 56.88% to $226,092 in 2016, then slumped by 88.37% to $36,078 in 2017.
  • Its Other Non-Current Liabilities was $36,078 in Q3 2017, compared to $72,157 in Q2 2017 and $55,320 in Q1 2017.